These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38038339)

  • 1. Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial.
    Zhou Z; Tonkin AM; Curtis AJ; Murray A; Zhu C; Reid CM; Williamson JD; Ryan J; McNeil JJ; Beilin LJ; Ernst ME; Stocks N; Lacaze P; Shah RC; Woods RL; Wolfe R; Gall S; Zoungas S; Orchard SG; Nelson MR
    J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38038339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-dependent associations of plasma high-density lipoprotein cholesterol and mortality risk in healthy older men and women: two prospective cohort studies.
    Hussain SM; Tonkin AM; Watts GF; Lacaze P; Yu C; Beilin LJ; Zhou Z; Newman AB; Neumann JT; Tran C; McNeil JJ
    Geroscience; 2024 Apr; 46(2):1461-1475. PubMed ID: 37610595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between lipoprotein cholesterol and future cardiovascular disease and mortality in older adults: a Korean nationwide longitudinal study.
    Kim SH; Son KY
    Lipids Health Dis; 2021 Jan; 20(1):3. PubMed ID: 33407561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between low-density and non-high-density lipoprotein cholesterol with incident cardiovascular disease among low-risk Iranians during 2 decades follow-up.
    Tohidi M; Asgari S; Chary A; Azizi F; Hadaegh F
    Clin Biochem; 2022; 109-110():28-36. PubMed ID: 35970222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between high-density lipoprotein cholesterol level and cardiovascular disease and all-cause mortality in the elderly population].
    Yu JX; Wu SL; Chen SH; Liu Y; Feng MK; Yang Y; Li SJ; Liu XK; Yang N; Li YM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Aug; 50(8):791-798. PubMed ID: 35982012
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study.
    Johannesen CDL; Langsted A; Mortensen MB; Nordestgaard BG
    BMJ; 2020 Dec; 371():m4266. PubMed ID: 33293274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study.
    Yu Y; Li M; Huang X; Zhou W; Wang T; Zhu L; Ding C; Tao Y; Bao H; Cheng X
    Lipids Health Dis; 2020 Nov; 19(1):238. PubMed ID: 33183311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hypertriglyceridaemia on cardiovascular mortality according to low-density lipoprotein cholesterol in a 15.6-million population.
    Park HB; Arsanjani R; Hong SJ; Yi JJ; Yi SW
    Eur J Prev Cardiol; 2024 Feb; 31(3):280-290. PubMed ID: 37850354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol.
    Luo Y; Peng D
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231189597. PubMed ID: 37641208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality.
    Cui Y; Blumenthal RS; Flaws JA; Whiteman MK; Langenberg P; Bachorik PS; Bush TL
    Arch Intern Med; 2001 Jun; 161(11):1413-9. PubMed ID: 11386890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
    J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between low-density lipoprotein cholesterol and cardiovascular mortality in statin non-users: a prospective cohort study in 14.9 million Korean adults.
    Yi SW; An SJ; Park HB; Yi JJ; Ohrr H
    Int J Epidemiol; 2022 Aug; 51(4):1178-1189. PubMed ID: 35218344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM; Newschaffer CJ; Klag MJ; Bush TL
    Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population.
    Rong S; Li B; Chen L; Sun Y; Du Y; Liu B; Robinson JG; Bao W
    J Am Heart Assoc; 2022 Aug; 11(15):e023690. PubMed ID: 35904192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
    Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
    Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
    Otvos JD; Guyton JR; Connelly MA; Akapame S; Bittner V; Kopecky SL; Lacy M; Marcovina SM; Muhlestein JB; Boden WE
    J Clin Lipidol; 2018; 12(2):348-355.e2. PubMed ID: 29409728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
    Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
    Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10-year diabetes cohort study.
    Wan EYF; Yu EYT; Chin WY; Barrett JK; Mok AHY; Lau CST; Wang Y; Wong ICK; Chan EWY; Lam CLK
    Diabetes Obes Metab; 2020 Oct; 22(10):1777-1788. PubMed ID: 32452623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
    Mora S; Buring JE; Ridker PM; Cui Y
    Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.